Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.39% to 7,015.20.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.55% to 6976.50.
The Australian dollar and bond yields slid after the Reserve Bank of Australia lifted the cash rate by 0.25% on Melbourne Cup Day, to 4.35%.
A positive lead from Wall Street, in which bad news on the economy became good news for stocks, resulted in the S&P/ASX 200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) gaining 1.9 per cent to begin the week.
The Imugene Limited (ASX: IMU) share price has taken a large hit today. Shares were down over 30% earlier today, but have since recovered slightly. Here’s my take.
The share price of biotechnology company Imugene Limited (ASX: IMU) has been on a tear this year. Here’s why the Imugene share price is flying.
